- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT05591989
Клиническая оценка безопасности и эффективности системы NEUROMARK у пациентов с хроническим ринитом (PARAGON)
Клиническая оценка безопасности и эффективности системы NEUROMARK у пациентов с хроническим ринитом (PARAGON) — проспективное многоцентровое клиническое исследование с одной группой.
The PARAGON Study is a prospective, single-arm, multicenter safety and efficacy study of the Neurent Medical NEUROMARK System in subjects with chronic rhinitis.
Обзор исследования
Тип исследования
Регистрация (Действительный)
Фаза
- Непригодный
Контакты и местонахождение
Места учебы
-
-
Alabama
-
Birmingham, Alabama, Соединенные Штаты, 35242
- Alabama Nasal and Sinus Center (Alabama Allergy)
-
-
California
-
California City, California, Соединенные Штаты, 95661
- Sacramento ENT
-
Temecula, California, Соединенные Штаты, 92592
- United Medical Doctors
-
-
Colorado
-
Colorado Springs, Colorado, Соединенные Штаты, 80923
- Colorado ENT
-
-
Louisiana
-
Marrero, Louisiana, Соединенные Штаты, 70072
- New Orleans Sinus Center
-
-
Maryland
-
Baltimore, Maryland, Соединенные Штаты, 21204
- Centers for Advanced ENT Care (CAdENT)
-
-
Michigan
-
Royal Oak, Michigan, Соединенные Штаты, 48073
- Rontal Clinics
-
-
Pennsylvania
-
Bethlehem, Pennsylvania, Соединенные Штаты, 18017
- Specialty Physician Associates
-
-
Virginia
-
Richmond, Virginia, Соединенные Штаты, 23235
- Richmond ENT
-
-
Washington
-
Seattle, Washington, Соединенные Штаты, 98374-1145
- Ear Nose Throat & Allergy Associates
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
Subjects MUST:
- Be ≥18 years of age.
- Have been experiencing rhinitis symptoms for a minimum of 6 months.
- Have moderate to severe symptoms of runny nose (individual rTNSS symptom rating of 2 or 3), mild to severe symptoms of nasal congestion (individual rTNSS symptom rating of 1,2, or 3), and a minimum total score of 5 (out of 12) at baseline.
- Have an allergy test (by skin prick or intradermal testing, or by a validated in vitroImmunoglobin E [IgE test]) on file within 5 years of the baseline visit or is willing to have one performed during the study prior to 6-month visit.
- Be an appropriate candidate for bilateral NEUROMARK® device treatment performed under local anesthesia.
- Test negative for active COVID-19 at the start of the study screening and continue to be free of COVID-19 symptoms until the time of enrollment/treatment.
- Be willing and able to comply with all study elements, as indicated by written informed consent.
Exclusion Criteria:
Subjects MUST NOT:
- Have clinically significant anatomic obstruction that in the investigator's opinion limit access to the posterior nose, including but not limited to severe septal deviation or perforation, nasal polyps, and/or sinonasal tumor.
- Have had previous sinus or nasal surgery within 6 months of study enrollment.
- Have previously undergone RF, cryotherapy, or other surgical interventions for rhinitis.
- Have an active nasal or sinus infection.
- Have nasal mucosal erosion/ulceration.
- Have rhinitis symptoms that are due to seasonal allergies only.
- Have plans to (or otherwise anticipates the need to) undergo an ENT procedure concurrently or within 6 months after the study procedure.
- Have started a new sinonasal medication regimen within 4 weeks prior to treatment that, according to the manufacturer's labelling, has not yet stabilized.
- Be on prescribed anticoagulants (eg, warfarin, Plavix) or ≥ 325 mg aspirin that cannot be held for an appropriate time before the procedure.
- Have a history of chronic epistaxis or experienced a significant epistaxis event (defined as epistaxis requiring medical intervention) in the past 3 months.
- Have numbness of the soft palate, excessive dry eye, excessive dry nose, or other indication of neuro/nerve compromise in the sinonasal cavity.
- Have an active rhinitis medicamentosa or a history of rhinitis medicamentosa within the past 6 months.
- Have been diagnosed with atrophic rhinitis.
- Have had previous head and/or neck irradiation.
- Have an allergy or intolerance to local anesthetic agents.
- Be pregnant.
- Have a physical, neurological, medical, psychiatric condition or situation that, in the investigator's opinion, puts the subject at risk, could confound the study results, or may interfere significantly with the subject's participation in the study.
- Be participating in another clinical research study.
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Уход
- Распределение: Н/Д
- Интервенционная модель: Одногрупповое задание
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: Treatment
Subjects will undergo treatment with the NEUROMARK System |
The NEUROMARK System is indicated for use in otorhinolaryngology (ENT) surgery for creation of radiofrequency (RF) lesions to disrupt posterior nasal nerves in patients with chronic rhinitis. |
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Total rTNSS Score 6M
Временное ограничение: 6-Month Follow Up
|
Change in total rTNSS score from baseline at 6-Month Follow up. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12). |
6-Month Follow Up
|
|
Device- and/or Procedure-related SAEs
Временное ограничение: 24-Month Follow Up
|
Number of participants who experienced a device- and/or procedure-related serious adverse event during the course of the study. |
24-Month Follow Up
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Total rTNSS Score 1M
Временное ограничение: 1-Month Follow Up
|
Change in total rTNSS score from baseline at the 1-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12). |
1-Month Follow Up
|
|
Total rTNSS Score 3M
Временное ограничение: 3-Month Follow Up
|
Change in total rTNSS score from baseline at the 3-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12). |
3-Month Follow Up
|
|
Total rTNSS Score 9M
Временное ограничение: 9-Month Follow Up
|
Change in total rTNSS score from baseline at 9-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12). |
9-Month Follow Up
|
|
Total rTNSS Score 12M
Временное ограничение: 12-Month Follow Up
|
Change in total rTNSS score from baseline at the 12-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12). |
12-Month Follow Up
|
|
Total rTNSS Score 15M
Временное ограничение: 15-Month Follow Up
|
Change in total rTNSS score from baseline at 15-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12). |
15-Month Follow Up
|
|
Total rTNSS Score 18M
Временное ограничение: 18-Month Follow Up
|
Change in total rTNSS score from baseline at 18-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12). |
18-Month Follow Up
|
|
Total rTNSS Score 21M
Временное ограничение: 21-Month Follow Up
|
Change in total rTNSS score from baseline at 21-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12). |
21-Month Follow Up
|
|
Total rTNSS Score 24M
Временное ограничение: 24-Month Follow Up
|
Change in rTNSS score from baseline at the final 24-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12). |
24-Month Follow Up
|
|
rTNSS Congestion Score 1M
Временное ограничение: 1-Month Follow Up
|
Change in rTNSS congestion subscore from baseline at the 1-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
1-Month Follow Up
|
|
rTNSS Rhinorrhea Score 1M
Временное ограничение: 1-Month Follow Up
|
Change in rTNSS rhinorrhea subscore from baseline at the 1-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
1-Month Follow Up
|
|
rTNSS Nasal Itching Score 1M
Временное ограничение: 1-Month Follow Up
|
Change in rTNSS nasal itching subscore from baseline at the 1-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
1-Month Follow Up
|
|
rTNSS Sneezing Score 1M
Временное ограничение: 1-Month Follow Up
|
Change in rTNSS sneezing subscore from baseline at the 1-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
1-Month Follow Up
|
|
rTNSS Congestion Score 3M
Временное ограничение: 3-Month Follow Up
|
Change in rTNSS congestion subscore from baseline at the 3-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
3-Month Follow Up
|
|
rTNSS Rhinorrhea Score 3M
Временное ограничение: 3-Month Follow Up
|
Change in rTNSS rhinorrhea subscore from baseline at the 3-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
3-Month Follow Up
|
|
rTNSS Nasal Itching Score 3M
Временное ограничение: 3-Month Follow Up
|
Change in rTNSS nasal itching subscore from baseline at the 3-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
3-Month Follow Up
|
|
rTNSS Sneezing Score 3M
Временное ограничение: 3-Month Follow Up
|
Change in rTNSS sneezing subscore from baseline at the 3-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
3-Month Follow Up
|
|
rTNSS Congestion Score 6M
Временное ограничение: 6-Month Follow Up
|
Change in rTNSS congestion subscore from baseline at the 6-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
6-Month Follow Up
|
|
rTNSS Rhinorrhea Score 6M
Временное ограничение: 6-Month Follow Up
|
Change in rTNSS rhinorrhea subscore from baseline at the 6-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
6-Month Follow Up
|
|
rTNSS Nasal Itching Score 6M
Временное ограничение: 6-Month Follow Up
|
Change in rTNSS nasal itching subscore from baseline at the 6-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
6-Month Follow Up
|
|
rTNSS Sneezing Score 6M
Временное ограничение: 6-Month Follow Up
|
Change in rTNSS sneezing subscore from baseline at the 6-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
6-Month Follow Up
|
|
rTNSS Congestion Score 9M
Временное ограничение: 9-Month Follow Up
|
Change in rTNSS congestion subscore from baseline at the 9-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
9-Month Follow Up
|
|
rTNSS Rhinorrhea Score 9M
Временное ограничение: 9-Month Follow Up
|
Change in rTNSS rhinorrhea subscore from baseline at the 9-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
9-Month Follow Up
|
|
rTNSS Nasal Itching Score 9M
Временное ограничение: 9-Month Follow Up
|
Change in rTNSS nasal itching subscore from baseline at the 9-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
9-Month Follow Up
|
|
rTNSS Sneezing Score 9M
Временное ограничение: 9-Month Follow Up
|
Change in rTNSS sneezing subscore from baseline at the 9-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
9-Month Follow Up
|
|
rTNSS Congestion Score 12M
Временное ограничение: 12-Month Follow Up
|
Change in rTNSS congestion subscore from baseline at the 12-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
12-Month Follow Up
|
|
rTNSS Rhinorrhea Score 12M
Временное ограничение: 12-Month Follow Up
|
Change in rTNSS rhinorrhea subscore from baseline at the 12-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
12-Month Follow Up
|
|
rTNSS Nasal Itching Score 12M
Временное ограничение: 12-Month Follow Up
|
Change in rTNSS nasal itching subscore from baseline at the 12-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
12-Month Follow Up
|
|
rTNSS Sneezing Score 12M
Временное ограничение: 12-Month Follow Up
|
Change in rTNSS sneezing subscore from baseline at the 12-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
12-Month Follow Up
|
|
rTNSS Congestion Score 15M
Временное ограничение: 15-Month Follow Up
|
Change in rTNSS congestion subscore from baseline at the 15-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
15-Month Follow Up
|
|
rTNSS Rhinorrhea Score 15M
Временное ограничение: 15-Month Follow Up
|
Change in rTNSS rhinorrhea subscore from baseline at the 15-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
15-Month Follow Up
|
|
rTNSS Nasal Itching Score 15M
Временное ограничение: 15-Month Follow Up
|
Change in rTNSS nasal itching subscore from baseline at the 15-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
15-Month Follow Up
|
|
rTNSS Sneezing Score 15M
Временное ограничение: 15-Month Follow Up
|
Change in rTNSS sneezing subscore from baseline at the 15-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
15-Month Follow Up
|
|
rTNSS Congestion Score 18M
Временное ограничение: 18-Month Follow Up
|
Change in rTNSS congestion subscore from baseline at the 18-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
18-Month Follow Up
|
|
rTNSS Rhinorrhea Score 18M
Временное ограничение: 18-Month Follow Up
|
Change in rTNSS rhinorrhea subscore from baseline at the 18-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
18-Month Follow Up
|
|
rTNSS Nasal Itching Score 18M
Временное ограничение: 18-Month Follow Up
|
Change in rTNSS nasal itching subscore from baseline at the 18-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
18-Month Follow Up
|
|
rTNSS Sneezing Score 18M
Временное ограничение: 18-Month Follow Up
|
Change in rTNSS sneezing subscore from baseline at the 18-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
18-Month Follow Up
|
|
rTNSS Congestion Score 21M
Временное ограничение: 21-Month Follow Up
|
Change in rTNSS congestion subscore from baseline at the 21-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
21-Month Follow Up
|
|
rTNSS Rhinorrhea Score 21M
Временное ограничение: 21-Month Follow Up
|
Change in rTNSS rhinorrhea subscore from baseline at the 21-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
21-Month Follow Up
|
|
rTNSS Nasal Itching Score 21M
Временное ограничение: 21-Month Follow Up
|
Change in rTNSS nasal itching subscore from baseline at the 21-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
21-Month Follow Up
|
|
rTNSS Sneezing Score 21M
Временное ограничение: 21-Month Follow Up
|
Change in rTNSS sneezing subscore from baseline at the 21-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
21-Month Follow Up
|
|
rTNSS Congestion Score 24M
Временное ограничение: 24-Month Follow Up
|
Change in rTNSS congestion subscore from baseline at the 24-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
24-Month Follow Up
|
|
rTNSS Rhinorrhea Score 24M
Временное ограничение: 24-Month Follow Up
|
Change in rTNSS rhinorrhea subscore from baseline at the 24-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
24-Month Follow Up
|
|
rTNSS Nasal Itching Score 24M
Временное ограничение: 24-Month Follow Up
|
Change in rTNSS nasal itching subscore from baseline at the 24-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
24-Month Follow Up
|
|
rTNSS Sneezing Score 24M
Временное ограничение: 24-Month Follow Up
|
Change in rTNSS sneezing subscore from baseline at the 24-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome. |
24-Month Follow Up
|
|
Total Mini-RQLQ Score 3M
Временное ограничение: 3-Month Follow Up
|
Change in total mini-RQLQ score from baseline at the 3-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score. |
3-Month Follow Up
|
|
Total Mini-RQLQ Score 6M
Временное ограничение: 6-Month Follow Up
|
Change in total mini-RQLQ score from baseline at the 6-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score. |
6-Month Follow Up
|
|
Total Mini-RQLQ Score 12M
Временное ограничение: 12-Month Follow Up
|
Change in total mini-RQLQ score from baseline at the 12-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score. |
12-Month Follow Up
|
|
Total Mini-RQLQ Score 18M
Временное ограничение: 18-Month Follow Up
|
Change in total mini-RQLQ score from baseline at the 18-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score. |
18-Month Follow Up
|
|
Total Mini-RQLQ Score 21M
Временное ограничение: 21-Month Follow Up
|
Change in total mini-RQLQ score from baseline at the 21-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score. |
21-Month Follow Up
|
|
Total Mini-RQLQ Score 24M
Временное ограничение: 24-Month Follow Up
|
Change in total mini-RQLQ score from baseline at the 24-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score. |
24-Month Follow Up
|
Соавторы и исследователи
Спонсор
Следователи
- Директор по исследованиям: Annalise Sorensen, Neurent Medical
Публикации и полезные ссылки
Общие публикации
- Yen DM, Davis GE, Ow RA, O'Malley EM, Del Signore AG. Two-Year Clinical Outcomes After Multipoint Impedance-Controlled Radiofrequency Ablation of the Posterior Nasal Nerve for Treatment of Chronic Rhinitis. Ear Nose Throat J. 2025 Oct 9:1455613251382759. doi: 10.1177/01455613251382759. Online ahead of print.
- Davis GE, Ow RA, Yen DM, O'Malley EM, Del Signore AG. Clinical Outcomes After Innovative Multipoint Impedance-Controlled Radiofrequency Ablation of the Posterior Nasal Nerve for Treatment of Chronic Rhinitis. Ear Nose Throat J. 2024 Sep 24:1455613241285134. doi: 10.1177/01455613241285134. Online ahead of print.
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Действительный)
Завершение исследования (Действительный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- CIP-0007
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
продукт, произведенный в США и экспортированный из США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .